ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Melior Pharmaceuticals to initiate trial of Covid-19 drug
March 11, 2021Melior Pharmaceuticals is set to initiate a planned Phase II study of its novel, first-in-class lyn kinase activator, tolimidone, for Covid-19 treatment. -
Melior Pharmaceuticals awarded grant for advancing pulmonary therapeutic in Covid-19 phase 2 clinical trial
September 18, 2020Melior Pharmaceuticals has been awarded a grant from the Commonwealth of Pennsylvania’s COVID-19 Vaccines, Treatments and Therapies (CV-VTT) Program, which is designed to support rapid advancement of promising COVID-19 therapies.
Pharma Sources Insight January 2025
